Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Disease × Cyclophosphamide × Clear all

Phase

Status

Completed 4 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 57 Breast Neoplasms 54 Lymphoma 52 Multiple Myeloma 48 Leukemia 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Lymphoma, Non-Hodgkin 45 Melanoma 43 Lymphoma, Large B-Cell, Diffuse 40 Myelodysplastic Syndromes 39 Leukemia, Lymphocytic, Chronic, B-Cell 39 Lymphoma, Follicular 28 Hodgkin Disease 24 Burkitt Lymphoma 23 Neoplasm Metastasis 22 Recurrence 21 Neoplasms 21 Lymphoma, Mantle-Cell 19 Ovarian Neoplasms 17 Lymphoma, B-Cell, Marginal Zone 17 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17 Carcinoma, Non-Small-Cell Lung 17 Neoplasms, Plasma Cell 14 Myeloproliferative Disorders 14 Lymphoma, B-Cell 14 Hematologic Neoplasms 14 Primary Myelofibrosis 13 Leukemia, Myelomonocytic, Chronic 13 Carcinoma, Renal Cell 13 Triple Negative Breast Neoplasms 12

Interventions

obinutuzumab 1 ioflupane 1 idelalisib 1 daratumumab 1 alovudine 1 Vindesine 1 Vincristine 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Ga(III)-DOTATOC 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡